One of the world's largest pharmaceutical CDMOs through its Patheon pharma services division. Provides end-to-end pharmaceutical development and manufacturing services for both small molecules and biologics, from API manufacturing through drug product, sterile fill/finish, packaging, and commercial supply. Operates 31+ FDA-registered facilities globally. 158 FDA inspections on record (52 NAI, 104 VAI, 2 OAI). Also provides cell therapy manufacturing solutions (CTS Rotea cell processing system), laboratory informatics, bioprocessing equipment, and reagents. 4 FDA-approved drug products. Revenue >$40B (full company).
Patheon pharma services (full-service CDMO), API through finished dosage form, sterile manufacturing, hot melt extrusion, spray drying, lipid nanoparticle formulation, cell and gene therapy manufacturing, bioprocessing, global regulatory and supply chain management.
6 sites worldwide
No reviews available yet.
No documents available.